Upon normalizing the frequencies of IFN-γ+ RCAN1-422-32 peptide-reactive T cells to the total CD3+ T cell population in each sample, we observed a negligible increase in their mean percentage in the PBMCs of GBM patients compared with those of healthy individuals. This evidence concerns the gene RCAN1 and glioblastoma.